General information | DisProt: | DP00250 | Name: | Cholera enterotoxin subunit A | Synonym(s): | CHTA_VIBCH
Cholera enterotoxin, A chain
Cholera enterotoxin subunit A1 [cleavage product 1] (aa 19-212)
Cholera enterotoxin A1 chain
Cholera enterotoxin alpha chain
NAD(+)--diphthamide ADP-ribosyltransferase
Cholera enterotoxin subunit A2 [cleavage product 2] (aa 213-258)
Cholera enterotoxin A2 chain
Cholera enterotoxin gamma chain
| First appeared in release: | Release 3.0 (02/17/2006) | UniProt: | P01555 | UniGene: | | SwissProt: | CHTA_VIBCH | TrEMBL: | | NCBI (GI): | 116397 | Source organism: | Vibrio cholerae | Sequence length: | 258 | Percent disordered: | 4% | Homologues: | |
Native sequence |
10 20 30 40 50 60 | | | | | | MVKIIFVFFI FLSSFSYAND DKLYRADSRP PDEIKQSGGL MPRGQSEYFD RGTQMNINLY - 60 DHARGTQTGF VRHDDGYVST SISLRSAHLV GQTILSGHST YYIYVIATAP NMFNVNDVLG - 120 AYSPHPDEQE VSALGGIPYS QIYGWYRVHF GVLDEQLHRN RGYRDRYYSN LDIAPAADGY - 180 GLAGFPPEHR AWREEPWIHH APPGCGNAPR SSMSNTCDEK TQSLGVKFLD EYQSKVKRQI - 240 FSGYQSDIDT HNRIKDEL
|
Functional narrative |
The A1 chain catalyzes the ADP-ribosylation of Gs alpha, a GTP-binding regulatory protein, to activate the adenylate cyclase. This leads to an overproduction of cAMP and eventually to a hypersecretion of chloride and bicarbonate followed by water, resulting in the characteristic cholera stool. The A2 chain tethers A1 to the pentameric ring. (UniProt).
|
Map of ordered and disordered regions |


Note: 'Mouse' over a region to see the start and stop residues. Click on a region to see detailed information.
|
Region 1 | Type: | Ordered | Name: | Activation loop | Location: | 44 - 54 | Length: | 11 | Region sequence: |
GQSEYFDRGTQ | Modification type: | Monomeric
Mutant
Native
| PDB: | 1S5B:A, 1S5C:A, 1S5D:A, 1S5E:A, 1S5F:A | Structural/functional type: | Function arises via an order to disorder transition | Functional classes: | Entropic chain
| Functional subclasses: | Autoregulatory
| Detection methods:
- X-ray crystallography (298 K; pH: 7; CTY30S form 1; MES (pH 6 - 7) 100 mM; PEG 2000 monomethyl ether (14 - 20%); Protein (PBS buffer))
- X-ray crystallography (298 K; pH: 7; CTY30S form 2; D-galactose (Buffer G) 300 mM; PEG 3350 (20%); Protein (Buffer G); Sodium citrate 100 mM)
- X-ray crystallography (298 K; pH: 7; CTY30S form 3; Kemptide 250 mM; MES (pH 6 - 7) 100 mM; PEG 2000 monomethyl ether (14 - 20%); Protein (PBS buffer))
- X-ray crystallography (298 K; pH: 7; CT-wt form 1; D-galactose (Buffer G) 300 mM; Magnesium acetate 150 mM; PEG 3350 (18-20%); Protein (Buffer G))
- X-ray crystallography (298 K; pH: 7; CT-wt form 2; D-galactose (Buffer G) 300 mM; Lithium citrate 200 mM; PEG 3350 (20%); Protein (Buffer G))
| References:
- O'Neal CJ, Amaya EI, Jobling MG, Holmes RK, Hol WG. "Crystal structures of an intrinsically active cholera toxin mutant yield insight into the toxin activation mechanism." Biochemistry. 2004; 43(13): 3772-82. PubMed: 15049684
| Comments:After modification by limited proteolysis and/or disulfide bond reduction, this activation loop is thought to undergo a order-to-disorder transition that results in the destabilization of the active site loop.
Of the three CTY30S crystal forms, 1 and 3 show this region to be fully disordered, whereas residues 48-55 are shown to be disordered in form 2, with high B factors being seen for residues 45 - 47. The loop is ordered in the wt-CT, however, form 2 indicated high B factors for some of the residues along the loop, indicating a propensity towards disorder.
|
Region 2 | Type: | Ordered | Name: | Active site loop | Location: | 66 - 75 | Length: | 10 | Region sequence: |
TQTGFVRHDD | Modification type: | Monomeric
Mutant
Native
| PDB: | 1S5B:A, 1S5C:A, 1S5D:A, 1S5E:A, 1S5F:A | Structural/functional type: | Function arises via an order to disorder transition | Functional classes: | Unknown
| Functional subclasses: | Autoregulatory
| Detection methods:
- X-ray crystallography (298 K; pH: 7; CTY30S form 1; MES (pH 6 - 7) 100 mM; PEG 2000 monomethyl ether (14 - 20%); Protein (PBS buffer))
- X-ray crystallography (298 K; pH: 7; CTY30S form 2; D-galactose (Buffer G) 300 mM; PEG 3350 (20%); Protein (Buffer G) 100 mM; Sodium citrate)
- X-ray crystallography (298 K; pH: 7; CTY30S form 3; Kemptide 250 mM; MES (pH 6 - 7) 100 mM; PEG 2000 monomethyl ether (14 - 20%); Protein (PBS buffer))
- X-ray crystallography (298 K; pH: 7; CT-wt form 1; D-galactose (Buffer G) 300 mM; Magnesium acetate 150 mM; PEG 3350 (18-20%); Protein (Buffer G))
- X-ray crystallography (298 K; pH: 7; CT-wt form 2; D-galactose (Buffer G) 300 mM; Lithium citrate 200 mM; PEG 3350 (20%); Protein (Buffer G))
| References:
- O'Neal CJ, Amaya EI, Jobling MG, Holmes RK, Hol WG. "Crystal structures of an intrinsically active cholera toxin mutant yield insight into the toxin activation mechanism." Biochemistry. 2004; 43(13): 3772-82. PubMed: 15049684
| Comments:It is thought that destabilization of the active site loop makes it more flexible, thus allowing substrates to enter the active site, which undergo ADP-ribosylation.
The active site loop is ordered in the wild-type structures, in addition to CTY30S forms 1 and 2. With the addition of the kemptide inhibitor to CTY30S form 3, poor electron density was seen for residues 66 - 71, a possible indication of a order-to-disorder transition of the active site loop when substrate binds.
|
Region 3 | Type: | Disordered - Extended | Name: | KDEL binding region | Location: | 245 - 255 | Length: | 11 | Region sequence: |
QSDIDTHNRIK | Modification type: | Monomeric
Mutant
Native
| PDB: | 1S5B:A, 1S5C:A, 1S5D:A, 1S5E:A, 1S5F:A | Structural/functional type: | Relationship to function unknown | Functional classes: | Unknown
| Functional subclasses: | Protein-protein binding
| Detection methods:
- X-ray crystallography (298 K; pH: 7; CTY30S form 1; MES (pH 6 - 7) 100 mM; PEG 2000 monomethyl ether (14 - 20%); Protein (PBS buffer))
- X-ray crystallography (298 K; pH: 7; CTY30S form 2; D-galactose (Buffer G) 300 mM; PEG 3350 (20%); Protein (Buffer G); Sodium citrate 100 mM)
- X-ray crystallography (298 K; pH: 7; CTY30S form 3; Kemptide 250 mM; MES (pH 6 - 7) 100 mM; PEG 2000 monomethyl ether (14 - 20%); Protein (PBS buffer))
- X-ray crystallography (298 K; pH: 7; CT-wt form 1; D-galactose (Buffer G) 300 mM; Magnesium acetate 150 mM; PEG 3350 (18-20%); Protein (Buffer G))
- X-ray crystallography (298 K; pH: 7; CT-wt form 2; D-galactose (Buffer G) 300 mM; Lithium citrate 200 mM; PEG 3350 (20%); Protein (Buffer G))
| References:
- O'Neal CJ, Amaya EI, Jobling MG, Holmes RK, Hol WG. "Crystal structures of an intrinsically active cholera toxin mutant yield insight into the toxin activation mechanism." Biochemistry. 2004; 43(13): 3772-82. PubMed: 15049684
| Comments:All crystal structures showed an elongated conformation for the disordered region of A2. This region extends through the B5 pore of of CT-subunit B in order to interact with the KDEL receptor.
|
References |
- Lockman HA, Galen JE, Kaper JB. "Vibrio cholerae enterotoxin genes: nucleotide sequence analysis of DNA encoding ADP-ribosyltransferase." J Bacteriol. 1984; 159(3): 1086-9. PubMed: 6090390
- Lockman H, Kaper JB. "Nucleotide sequence analysis of the A2 and B subunits of Vibrio cholerae enterotoxin." J Biol Chem. 1983; 258(22): 13722-6. PubMed: 6315707
|
Comments |
Crystallography by O'Neal et al (2004) was performed on the full length protein minus the signal peptide (aa 1-18), therefore the disordered regions are attached to the parent protein rather than cleavage products (subunits A1 and A2). DP regions are numbered according the the whole protein, the O'Neal paper disregards the signal peptide (author's aa 1 = DisProt/UniProt aa 19).
|
If you have any comments or wish to provide additional references to this protein or its disordered region(s), please click here to e-mail us. |
Disprot-footer
|